Louisiana 2018 Regular Session

Louisiana Senate Bill SR145

Introduced
4/24/18  
Introduced
4/24/18  
Refer
4/25/18  
Refer
4/25/18  
Report Pass
5/2/18  
Report Pass
5/2/18  
Passed
5/3/18  

Caption

Requests the Department of Insurance to study insurer's coverage of diabetes-related medication.

Impact

If enacted, SR145 would have implications for state health insurance regulations and the assessment of healthcare delivery for diabetes management. The result of the study could lead to recommendations that enhance coverage for diabetes-related medications, potentially influencing future legislative measures that address healthcare affordability and accessibility for those with chronic illnesses. This may consequently improve health outcomes for individuals suffering from diabetes by ensuring they receive necessary treatments without financial hardship.

Summary

Senate Resolution 145 (SR145) requests the Department of Insurance to conduct a study regarding insurance coverage for diabetes-related medications. The resolution emphasizes the need to assess the effectiveness and accessibility of current insurance practices that affect diabetes care and management. It aims to understand the scope of coverage provided by insurers, particularly focusing on how it can impact individuals living with diabetes and the challenges they face in accessing essential medication.

Sentiment

The sentiment surrounding SR145 seems to be generally supportive, particularly among healthcare advocates and diabetes advocacy groups. Many view the study as a proactive step towards better understanding and potentially rectifying gaps in insurance coverage for diabetes medications. However, there may also be concerns about the timely execution and resultant actions from the study, especially in the currently evolving landscape of healthcare insurance.

Contention

Notable points of contention may arise regarding the scope of the study and the interpretations of its findings. Concerns may include how thoroughly the Department of Insurance will evaluate the existing insurance policies and whether the recommendations will translate into meaningful changes for policyholders. Stakeholders could debate the adequacy of such studies, particularly in terms of addressing systemic issues related to diabetes care accessibility and affordability within the broader context of state healthcare policies.

Companion Bills

No companion bills found.

Previously Filed As

LA SR49

Requests a study of the decline in health insurance coverage among children in the state.

LA SR60

Requests the Department of Insurance to create a task force to study the causes of infertility in women and mandating insurance coverage of fertility treatments for women.

LA SR97

Requests the Department of Insurance to create a task force to study the causes of infertility in women and mandating insurance coverage of fertility treatments for women.

LA SR95

Requests the Department of Insurance to create a task force to study best practices for coverage of long-term supports and services.

LA SR150

Requests Senate Committee on Insurance to study health insurance issuers providing coverage of medications for sexual performance enhancement.

LA HR337

Requests the Department of Insurance to study and issue a report relative to the impact of health insurance coverage mandates on the cost of health insurance

LA HCR92

Requests study by Louisiana Department of Health to consider Medicaid coverage of gene therapy

LA SCR14

Requests the New Orleans East Hospital to become a Diabetes Education and Research Center.

LA SCR55

Requests the Louisiana Department of Insurance to assemble a task force to address the high automobile insurance rates in the state.

LA HB233

Diabetic Foot Ulcer Equipment Coverage

Similar Bills

No similar bills found.